The MTAP gene helps cells recycle a small molecule made during normal growth, which supports the supply of methionine and adenine that cells need to function. The protein made by this gene helps your cells reuse these materials instead of letting them build up. If the gene does not work or is missing, cells can lose part of this recycling system, and in some cancers this loss is linked to tumor growth and may affect how tumors respond to treatment.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating activities in the body. Some genes carry the information needed to produce proteins, which are the parts of cells that do the work. Other genes mainly control when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. If you want to look into this topic more closely, you can find more in the LearnHub.
Overview
MTAPGene function
What if the gene works
The MTAP gene helps cells recycle certain small molecules into materials used to make DNA and proteins. This supports normal cell growth and everyday cell maintenance.
Risk
What if the gene does not work
Rare variants in the MTAP gene can cause a metabolic condition with delayed development and floppiness, while other variants are linked to a long bone condition that can raise bone cancer risk. Effects can range from milder to more severe.
Treatment
What does that mean for your treatment
No treatment or drug choice specifically guided by variants in the MTAP gene is currently established in clinical guidelines. In cancer care, loss of the MTAP gene is being studied as a biomarker for medicines that target PRMT5 or MAT2A, but these approaches remain investigational rather than standard treatment.
Conditions associated with MTAP
Gene function
What if the gene works
Your cells are constantly recycling small molecules so they can keep growing, repairing, and dividing. The MTAP gene supports this cleanup and reuse system. Knowing what the MTAP gene does in your body helps explain how cells reuse important materials every day.
MTAP breaks down methylthioadenosine (MTA), a small leftover molecule from normal cell work. This lets cells recycle useful parts instead of leaving that byproduct to build up.
By processing MTA, this gene helps cells recover material used to remake methionine, an amino acid needed for proteins and many other cell tasks. This supports steady everyday metabolism.
MTAP also helps cells recover adenine, a chemical piece they can reuse to make DNA, RNA, and energy carrying molecules. That recycling helps keep basic cell activity supplied.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variations in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many MTAP gene variants change the enzyme’s shape, so it becomes unstable, works less well, or is broken down too soon. Some variants only partly lower activity, while more disruptive changes can leave cells with little or no working enzyme. This can cause buildup of methylthioadenosine (a small molecule cells usually reuse) and reduce recycling of important cell building blocks.
How variants are linked to conditions
Pathogenic variants in the MTAP gene are best known for causing diaphyseal medullary stenosis with malignant fibrous histiocytoma, a rare inherited condition that affects the long bones and can raise the chance of certain bone or soft tissue tumors. In MTAP gene variants linked to conditions, this is the clearest and most widely accepted inherited association. Separate, noninherited loss of the MTAP gene is also often found in several cancers, including glioblastoma, mesothelioma, and pancreatic cancer.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and instead represent natural variation among people. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the MTAP gene. If testing has found a change in MTAP, a doctor or genetic counselor can explain what it may mean in the context of your personal and family history.
Inheritance of MTAP variants
MTAP-related conditions are inherited in an autosomal recessive pattern. This means a person usually inherits one MTAP gene variant from each parent, and parents who each carry one variant are typically unaffected. For each pregnancy, two carriers have a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial variant. In practical terms, how MTAP gene variants are inherited usually means the condition appears only when both copies of the gene are affected.
What does my MTAP result mean for my family?
For the rare inherited condition linked to the MTAP gene, the pattern is recessive, which means close relatives may be carriers even if they do not have symptoms. Brothers and sisters of an affected child may also be affected or may carry the family variant, so the result can matter for siblings and future pregnancies. In many families, parents are healthy carriers, and other relatives may wish to learn whether they carry the same change.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the MTAP gene, doctors use genetic testing for variants in the MTAP gene on a blood or saliva sample. A lab reads the DNA code and may also check whether part or all of the gene is missing. Results can show a benign variant, an uncertain finding, or a variant linked to disease.
When should I consider getting a genetic test?
Consider MTAP testing when a child has unexplained developmental delay, unusual movement problems, seizures, or other signs of the very rare inherited condition caused by changes in both copies of the MTAP gene. It can also help when there is a known family history or when relatives want to know whether they carry the same gene change.
A genetic result is only one part of your health story
A genetic result can be very informative, but how much it reveals depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at the target tissue. This helps explain why the same treatment works well for one person, seems less effective for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It looks for links between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the MTAP gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so questions about side effects, new symptoms, or how well treatment is working are best discussed with your doctor. Researchers are studying MTAP because tumors that have lost MTAP may respond differently to some newer cancer drugs, but this is still an area of ongoing research rather than routine care.
History
The MTAP gene entered cancer research through studies of chromosome 9p21, a region often lost in tumor cells. In the 1990s, researchers recognized that MTAP is frequently deleted alongside the nearby CDKN2A gene, which made it a useful marker in cancer genetics. From these first observations, research expanded steadily. Scientists then linked MTAP loss to several cancers, including glioblastoma, mesothelioma, and some leukemias, helping refine how tumors are classified in the lab. Over time, the gene’s role in cancer biology became clearer, not as a public-facing gene story, but as an important part of how researchers study tumor development and treatment targets.